Have a personal or library account? Click to login
Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History) Cover

Mechanisms Underlying Dopamine-Induced Risky Choice in Parkinson’s Disease With and Without Depression (History)

Computational Psychiatry
Volume 2 (2018): Issue 0
By: Monique H. M. Timmer,  Guillaume Sescousse,  Rianne A. J. Esselink,  Payam Piray and  Roshan Cools  
Open Access
|Feb 2018

References

  1. Beck, A. T., Erbaugh, J., Ward, C. H., Mock, J., & Mendelsohn, M. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.
    Back to article
  2. Bishop, C. M. (2006). Pattern recognition and machine learning. New York, NY: Springer.
    Back to article
  3. Brand, M., Labudda, K., Kalbe, E., Hilker, R., Emmans, D., Fuchs, G., … Markowitsch, H. J. (2004). Decision-making impairments in patients with Parkinson’s disease. Behavioural Neurology, 15(3–4), 77–85.
    Back to article
  4. Collins, A. G. E., & Frank, M. J. (2014). Opponent actor learning (OpAL): Modeling interactive effects of striatal dopamine on reinforcement learning and choice incentive. Psychological Review, 121, 337–366. doi:10.1037/a0037015
    Back to article
  5. Cools, R. (2006). Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson’s disease. Neuroscience and Biobehavioral Reviews, 30, 1–23. doi:10.1016/j.neubiorev.2005.03.024
    Back to article
  6. Cools, R., Altamirano, L., & D’Esposito, M. (2006). Reversal learning in Parkinson’s disease depends on medication status and outcome valence. Neuropsychologia, 44, 1663–1673. doi:10.1016/j.neuropsychologia.2006.03.030
    Back to article
  7. Cools, R., Barker, R. A., Sahakian, B. J., & Robbins, T. W. (2001). Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cerebral Cortex, 11, 1136–1143. doi:10.1093/cercor/11.12.1136
    Back to article
  8. Cools, R., Barker, R. A., Sahakian, B. J., & Robbins, T. W. (2003). L-DOPA medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease. Journal of Psychopharmacology, 17(3), A57.
    Back to article
  9. Cools, R., & D’Esposito, M. (2011). Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biological Psychiatry, 69, E113–E125. doi:10.1016/j.biopsych.2011.03.028
    Back to article
  10. Dagher, A., & Robbins, T. W. (2009). Personality, addiction, dopamine: Insights from Parkinson’s disease. Neuron, 61, 502–510. doi:10.1016/j.neuron.2009.01.031
    Back to article
  11. De Martino, B., Camerer, C. F., & Adolphs, R. (2010). Amygdala damage eliminates monetary loss aversion. Proceedings of the National Academy of Sciences of the United States of America, 107, 3788–3792. doi:10.1073/pnas.0910230107
    Back to article
  12. Efron, B., & Tibshirani, R. J.(1993). An introduction to the bootstrap. New York, NY: Chapman and Hall.
    Back to article
  13. Esselink, R. A. J., de Bie, R. M. A., de Haan, R. J., Lenders, M., Nijssen, P. C. G., Staal, M. J., … Speelman, J. D. (2004). Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: A randomized trial. Neurology, 62, 201–207.
    Back to article
  14. Euteneuer, F., Schaefer, F., Stuermer, R., Boucsein, W., Timmermann, L., Barbe, M. T., … Kalbe, E. (2009). Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson’s disease: A neuropsychological and psychophysiological study. Neuropsychologia, 47, 2882–2890. doi:10.1016/j.neuropsychologia.2009.06.014
    Back to article
  15. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental State: Practical method for grading cognitive state of patients for clinician. Journal of Psychiatric Research, 12, 189–198. doi:10.1016/0022-3956(75)90026-6
    Back to article
  16. Frank, M. J., Seeberger, L. C., & O’Reilly, R. C. (2004). By carrot or by stick: Cognitive reinforcement learning in Parkinsonism. Science, 306, 1940–1943. doi:10.1126/science.1102941
    Back to article
  17. Friston, K. J., Schwartenbeck, P., FitzGerald, T., Moutoussis, M., Behrens, T., & Dolan, R. J. (2013). The anatomy of choice: Active inference and agency. Frontiers in Human Neuroscience, 7, Article 598. doi:10.3389/fnhum.2013.00598
    Back to article
  18. Gibb, W. R. G., & Lees, A. J. (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 51, 745–752. doi:10.1136/jnnp.51.6.745
    Back to article
  19. Giorgetta, C., Grecucci, A., Rattin, A., Guerreschi, C., Sanfey, A. G., & Bonini, N. (2014). To play or not to play: A personal dilemma in pathological gambling. Psychiatry Research, 219, 562–569. doi:10.1016/j.psychres.2014.06.042
    Back to article
  20. Goetz, C. G., & Stebbins, G. T. (2004). Assuring interrater reliability for the UPDRS motor section: Utility of the UPDRS teaching tape. Movement Disorders, 19, 1453–1456. doi:10.1002/mds.20220
    Back to article
  21. Huys, Q. J. M., Cools, R., Goelzer, M., Friedel, E., Heinz, A., Dolan, R. J., & Dayan, P. (2011). Disentangling the roles of approach, activation and valence in instrumental and Pavlovian responding. PLoS Computational Biology, 7(4), e1002028. doi:10.1371/journal.pcbi.1002028
    Back to article
  22. Huys, Q. J. M., Eshel, N., O’Nions, E., Sheridan, L., Dayan, P., & Roiser, J. P. (2012). Bonsai trees in your head: How the Pavlovian system sculpts goal-directed choices by pruning decision trees. PLoS Computational Biology, 8(3), e1002410. doi:10.1371/journal.pcbi.1002410
    Back to article
  23. Joutsa, J., Martikainen, K., Vahlberg, T., Voon, V., & Kaasinen, V. (2012). Impulse control disorders and depression in Finnish patients with Parkinson’s disease. Parkinsonism & Related Disorders, 18, 155–160. doi:10.1016/j.parkreldis.2011.09.007
    Back to article
  24. Kahneman, D., & Tversky, A. (1979). Prospect theory—analysis of decision under risk. Econometrica, 47, 263–291. doi:10.2307/1914185
    Back to article
  25. Kahneman, D., & Tversky, A. (1984). Choices, values, and frames. American Psychologist, 39, 341–350. doi:10.1037/0003-066x.39.4.341
    Back to article
  26. Kakade, S., & Dayan, P. (2002). Dopamine: Generalization and bonuses. Neural Networks, 15, 549–559. doi:10.1016/s0893-6080(02)00048-5
    Back to article
  27. Kass, R. E., & Raftery, A. E. (1995). Bayes factors. Journal of the American Statistical Association, 90, 773–795. doi:10.1080/01621459.1995.10476572
    Back to article
  28. Norbury, A., Manohar, S., Rogers, R. D., & Husain, M. (2013). Dopamine modulates risk-taking as a function of baseline sensation-seeking trait. Journal of Neuroscience, 33, 12982–12986. doi:10.1523/jneurosci.5587-12.2013
    Back to article
  29. Piray, P., Zeighami, Y., Bahrami, F., Eissa, A. M., Hewedi, D. H., & Moustafa, A. A. (2014). Impulse control disorders in Parkinson’s disease are associated with dysfunction in stimulus valuation but not action valuation. Journal of Neuroscience, 34, 7814–7824. doi:10.1523/jneurosci.4063-13.2014
    Back to article
  30. Remy, P., Doder, M., Lees, A., Turjanski, N., & Brooks, D. (2005). Depression in Parkinson’s disease: Loss of dopamine and noradrenaline innervation in the limbic system. Brain, 128, 1314–1322. doi:10.1093/brain/awh445
    Back to article
  31. Rigoli, F., Rutledge, R. B., Chew, B., Ousdal, O. T., Dayan, P., & Dolan, R. J. (2016). Dopamine increases a value-independent gambling propensity. Neuropsychopharmacology, 41, 2658–2667. doi:10.1038/npp.2016.68
    Back to article
  32. Robbins, T. W., & Cools, R. (2014). Cognitive deficits in Parkinson’s disease: A cognitive neuroscience perspective. Movement Disorders, 29, 597–607. doi:10.1002/mds.25853
    Back to article
  33. Rutledge, R. B., Skandali, N., Dayan, P., & Dolan, R. J. (2015). Dopaminergic modulation of decision making and subjective well-being. Journal of Neuroscience, 35, 9811–9822.
    Back to article
  34. Schmand, B., Bakker, D., Saan, R., & Louman, J. (1991). The Dutch Reading Test for Adults: A measure of premorbid intelligence level. Tijdschrift voor Gerontologie en Geriatrie, 22(1), 15–19.
    Back to article
  35. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., … Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22–33.
    Back to article
  36. Shiba, M., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., … Rocca, W. A. (2000). Anxiety disorders and depressive disorders preceding Parkinson’s disease: A case-control study. Movement Disorders, 15, 669–677. doi:10.1002/1531-8257(200007)15:4¡669::AID-MDS1011¿3.0.CO;2-5
    Back to article
  37. Shiner, T., Seymour, B., Wunderlich, K., Hill, C., Bhatia, K. P., Dayan, P., & Dolan, R. J. (2012). Dopamine and performance in a reinforcement learning task: Evidence from Parkinson’s disease. Brain, 135, 1871–1883. doi:10.1093/brain/aws083
    Back to article
  38. Smittenaar, P., Chase, H. W., Aarts, E., Nusselein, B., Bloem, B. R., & Cools, R. (2012). Decomposing effects of dopaminergic medication in Parkinson’s disease on probabilistic action selection: Learning or performance? European Journal of Neuroscience, 35, 1144–1151. doi:10.1111/j.1460-9568.2012.08043.x
    Back to article
  39. St. Onge, J. R., Chiu, Y. C., & Floresco, S. B. (2010). Differential effects of dopaminergic manipulations on risky choice. Psychopharmacology, 211, 209–221. doi:10.1007/s00213-010-1883-y
    Back to article
  40. St. Onge, J. R., & Floresco, S. B. (2009). Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology, 34, 681–697. doi:10.1038/npp.2008.121
    Back to article
  41. Swainson, R., Rogers, R. D., Sahakian, B. J., Summers, B. A., Polkey, C. E., & Robbins, T. W. (2000). Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: Possible adverse effects of dopaminergic medication. Neuropsychologia, 38, 596–612. doi:10.1016/s0028-3932(99)00103-7
    Back to article
  42. Thaler, R. H., & Johnson, E. J. (1990). Gambling with the house money and trying to break even: The effects of prior outcomes on risky choice. Management Science, 36, 643–660. doi:10.1287/mnsc.36.6.643
    Back to article
  43. Tom, S. M., Fox, C. R., Trepel, C., & Poldrack, R. A. (2007). The neural basis of loss aversion in decision-making under risk. Science, 315, 515–518. doi:10.1126/science.1134239
    Back to article
  44. van der Schaaf, M. E., van Schouwenburg, M. R., Geurts, D. E., Schellekens, A. F., Buitelaar, J. K., Verkes, R. J., & Cools, R. (2014). Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning. Cerebral Cortex, 24, 633–642 . doi:10.1093/cercor/bhs344
    Back to article
  45. Voon, V., Gao, J., Brezing, C., Symmonds, M., Ekanayake, V., Fernandez, H., … Hallett, M. (2011). Dopamine agonists and risk: Impulse control disorders in Parkinson’s disease. Brain, 134, 1438–1446. doi:10.1093/brain/awr080
    Back to article
  46. Voon, V., Sohr, M., Lang, A. E., Potenza, M. N., Siderowf, A. D., Whetteckey, J., … Stacy, M. (2011). Impulse Control Disorders in Parkinson Disease: A Multicenter Case-Control Study. Annals of Neurology, 69, 986–996. doi:10.1002/ana.22356
    Back to article
  47. Vriend, C., Raijmakers, P., Veltman, D. J., van Dijk, K. D., van der Werf, Y. D., Foncke, E. M., … van den Heuvel, O. A. (2013). Depressive symptoms in Parkinson’s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. Journal of Neurology, Neurosurgery & Psychiatry, 85, 159–164. doi:10.1136/jnnp-2012-304811
    Back to article
  48. Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., … Lang, A. E. (2010). Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Archives of Neurology, 67, 589–595.
    Back to article
  49. Weintraub, D., Mamikonyan, E., Papay, K., Shea, J. A., Xie, S. X., & Siderowf, A. (2012). Questionnaire for impulsive-compulsive disorders in Parkinson’s Disease-Rating Scale. Movement Disorders, 27, 242–247. doi:10.1002/mds.24023
    Back to article
  50. Weintraub, D., Newberg, A. B., Cary, M. S., Siderowf, A. D., Moberg, P. J., Kleiner-Fisman, G., … Katz, I. R. (2005). Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson’s disease. Journal of Nuclear Medicine, 46, 227–232.
    Back to article
DOI: https://doi.org/10.1162/CPSY_a_00011 | Journal eISSN: 2379-6227
Journal RSS Feed
Language: English
Submitted on: Feb 1, 2017
Accepted on: Jun 3, 2017
Published on: Feb 1, 2018
Published by: MIT Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Parkinson’s disease,
depression,
risky choice,
dopamine,
loss aversion,
prospect theory

© 2018 Monique H. M. Timmer, Guillaume Sescousse, Rianne A. J. Esselink, Payam Piray, Roshan Cools, published by MIT Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 2 (2018): Issue 0Next article